Skip to content
中文产业新闻精选评分63Chinese source

罗氏BTK抑制剂fenebrutinib申报多发性硬化上市并获优先审评

罗氏：BTK抑制剂多发性硬化申报上市，获优先审评

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.